Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

$300M Fund to Back European Life Science Companies

A new investment fund plans to invest $300 million in European life science and biotechnology companies in the later stages of their product development. . . . → Read More: $300M Fund to Back European Life Science Companies

What Does The Future Hold For Investment?

The investment opportunities available to us in the modern day? They are large, wide and varied. . . . → Read More: What Does The Future Hold For Investment?

Report: Growing Tech Industry Investment in Health

The information technology industry is a growing presence in health care, both financially and qualitatively, according to a new report. . . . → Read More: Report: Growing Tech Industry Investment in Health

Fund Created for Point-of-Care Diagnostics, Treatment

A venture capital company is beginning a $60 million investment fund that plans to finance start-up enterprises providing point-of-care diagnostics and medical treatments. . . . → Read More: Fund Created for Point-of-Care Diagnostics, Treatment

Liquid Biopsy Company Gains $360M for Cancer Sequencing

A company using blood tests to diagnose cancer is receiving a $360 million investment for its campaign to sequence DNA from 1 million people at high risk of cancer. . . . → Read More: Liquid Biopsy Company Gains $360M for Cancer Sequencing

$2 Billion Biotech Licensing Deal Cancelled

A licensing deal with a potential value of more than $2 billion between two biotechnology companies for a new breast cancer drug was cancelled on Friday. . . . → Read More: $2 Billion Biotech Licensing Deal Cancelled

Gene Therapy Start-Up Raises $41M in Early Funds

A 1 year-old enterprise developing gene therapies to treat rare inherited metabolic disorders is raising €37.5 million ($US 40.8 million) in its first venture funding round. . . . → Read More: Gene Therapy Start-Up Raises $41M in Early Funds

Cancer Gene Therapy Company Raises $85M in IPO

A developer of cancer immunotherapies that transfer gene treatments into patients with brain tumors is raising $85 million in its initial public stock offering. . . . → Read More: Cancer Gene Therapy Company Raises $85M in IPO

Organ Transplant Start-Up Gains $38M in Early Funds

A one year-old company applying genome editing to make animal organs fit for human transplantation is raising $38 million its first venture funding round. . . . → Read More: Organ Transplant Start-Up Gains $38M in Early Funds

Medical Robotics Company Crowdfunding IPO

A medical robotics company spun-off from labs at MIT is issuing its initial public stock offering through equity crowdfunding, aiming to raise $15 million. . . . → Read More: Medical Robotics Company Crowdfunding IPO